U.S. Residential REITs Stock News

Ichor Holdings, Ltd. reported second-quarter 2026 results showing sales of US$294.78 million and net income of US$0.998 million, a shift from a loss a year earlier, and issued third-quarter revenue guidance of US$315 million to US$345 million with expected GAAP diluted EPS between US$0.25 and US$0.35. These results indicate improved profitability and higher sales compared with the prior year period, while the company’s forward guidance offers investors clearer expectations around revenue and...

With investors glued to upcoming US inflation data, oil price swings and firm Treasury yields, high dividend yield stocks are drawing fresh attention from anyone looking for steadier income while markets debate the Federal Reserve’s next move in September. This article looks at how those macro forces link back to company fundamentals and payout strength. You will see three stocks from the screener that appear positively exposed to the current backdrop. The three stocks highlighted below are...

Apnimed, Inc (NasdaqGS:APMD) has been added to the NASDAQ Composite Index following its recent IPO. The addition comes soon after Apnimed filed a shelf registration statement, signaling further corporate funding flexibility. Index inclusion typically draws attention from index-tracking funds and can affect trading volumes and liquidity. This kind of index move, combined with fresh IPO activity, points to a wider group of stocks that may be worth a closer look through 51 high quality...

Why nVent Electric’s latest earnings and expansion matter for investors nVent Electric (NVT) is in focus after reporting second quarter 2026 earnings, along with new manufacturing expansion plans for its data center liquid cooling business, tied to AI and high-performance computing demand. See our latest analysis for nVent Electric. The latest earnings release and data center expansion news come on top of strong momentum in nVent Electric’s stock, with a year to date share price return of...

Applied Optoelectronics, Inc. has reported its past second-quarter 2026 results, with sales rising to US$191.92 million from US$102.95 million a year earlier, while net loss widened to US$22.78 million and loss per share from continuing operations increased to US$0.28. Despite higher sales for both the quarter and first half of 2026, the company’s net losses and per-share losses also grew, highlighting the trade-off between rapid top-line expansion and the costs required to support that...

DXP Enterprises recently reported its Q2 2026 results, with sales rising to US$576.46 million and net income to US$28.71 million, alongside higher basic and diluted earnings per share from continuing operations compared with a year earlier. An interesting detail is that growth in the Innovative Pumping Solutions and Water platforms, supported by recent acquisitions, played a major role in lifting both revenue and earnings for the quarter and first half of 2026. With Q2 earnings buoyed by...

Upstart Holdings recently reported second-quarter 2026 results showing higher net income of US$16.54 million and reiterated its full-year 2026 revenue guidance of about US$1.40 billion. At the same time, Upstart expanded its funding reach through a new multi-year forward-flow agreement under which Castlelake-managed funds may buy up to US$4.00 billions of consumer loans originated on its platform over up to 24 months. Next, we’ll examine how reaffirmed revenue guidance combined with the...

Rexford Industrial Realty stock sits in a tricky spot for valuation minded investors. The Discounted Cash Flow (DCF) intrinsic value estimate lines up fairly closely with the current share price, while the market multiple view suggests the stock is trading at a premium and long term returns have been weak. Rexford Industrial Realty shareholders have seen the stock decline about 31% over the past 5 years, which raises questions about how much long term value has actually been created. The...

WaFd stock reaction and recent performance snapshot WaFd (WAFD) did not have a specific news event driving today’s move, yet the stock advanced to a last close of US$38.06, with 1 day and 7 day returns of 2.0% and 1.0%. Over the past month the share price was roughly flat with a slight decline of 0.1%, while the past 3 months show a 10.0% gain and the 1 year total return stands at 29.1%. See our latest analysis for WaFd. At around US$38.06, WaFd’s recent share price strength over the past...

Everest Group stock moves after mixed quarter and fresh shelf registration Everest Group (NYSE:EG) is back in focus after its second quarter 2026 results showed lower revenue and net income compared with a year earlier, alongside a new shelf registration for common stock. See our latest analysis for Everest Group. Everest Group shares trade at US$365.70 after a muted reaction to the second quarter earnings update, with a 90 day share price return of 5.1% and a 1 year total shareholder return...

FIFA’s leadership turmoil and talk of boycotts has put the business of global football under an uncomfortable spotlight, from billion dollar media rights to sponsorships tied to future World Cups. That disruption risk also creates an opening for investors watching sports media and broadcasting stocks exposed to this news. This article breaks down how three stocks from our screener are positioned, so you can judge whether the story fits your portfolio. The stocks covered below are just a...

With the July CPI release putting Federal Reserve rate expectations on a knife edge, interest rate sensitive U.S. REITs suddenly sit at the heart of the story rather than the sidelines. A softer inflation print could support rate relief hopes, while a hotter reading could do the opposite. This article walks through three REIT stocks exposed to that CPI outcome so you can see where opportunity and risk may be building right now. The three REITs below are just a starting sample, since the full...

AbbVie (NYSE:ABBV) said the FDA has accepted for review a supplemental Biologics License Application for BOTOX Cosmetic to treat masseter muscle prominence in the U.S. The filing positions BOTOX Cosmetic as a potential first approved neurotoxin for this jawline contouring indication, expanding AbbVie’s facial aesthetics reach beyond wrinkle treatment. AbbVie is seeking to build on Phase 3 data that supported efficacy and safety in adults seeking non surgical jawline contouring...

Piper Sandler’s downgrade of Samsara (IOT) to Neutral after a strong six month share run is putting fresh attention on slowing app-download trends and a bigger reliance on cross-selling for growth. See our latest analysis for Samsara. The downgrade comes after a strong run, with Samsara’s 90 day share price return of 41.85% and 1 year total shareholder return of 22.65% signaling momentum that is now starting to cool after today’s share price pullback. If this shift in sentiment has you...

Keel Infrastructure stock has delivered a very strong 176.4% return over the past year, yet the company only passes 1 of 6 valuation checks, which raises questions about how much of that performance is supported by fundamentals after recent setbacks. The 176.4% one year gain stands in sharp contrast to the recent pullback. This may signal that expectations built up faster than the market is now comfortable with. The shift away from U.S. Bitcoin mining toward AI and high performance computing...

Ingles Markets, Incorporated reported past third-quarter 2026 results with sales of US$1,368.32 million and net income of US$25.9 million, alongside higher nine‑month sales of US$4,049.16 million and net income of US$78.3 million versus the prior year. While quarterly earnings per share were almost unchanged, the nine‑month EPS from continuing operations rose to US$4.12, highlighting stronger year‑to‑date profitability despite a board resignation for personal reasons. We’ll now examine how...

Why Warner Music Group stock is back in focus Warner Music Group (WMG) has moved back onto investors radar after reporting third quarter earnings, reaffirming its full year guidance for high single digit revenue growth, and declaring a regular quarterly dividend. The company reported third quarter sales of US$1,864 million compared with US$1,689 million a year earlier, with net income of US$204 million after a net loss of US$16 million in the prior period. It also reiterated expectations for...

In the second quarter of 2026, BrightSpring Health Services reported revenue of US$3,873.14 million and net income of US$84.29 million, with earnings per share improving meaningfully from the prior year, and also lifted its full-year 2026 revenue outlook to a range of US$15.10 billion to US$15.43 billion. This combination of stronger profitability and higher guidance, underpinned by growth in the Specialty and Infusion pharmacy segment despite regulatory and customer pressures elsewhere,...

GEO Group has delivered a very strong 317.1% return over the last three years, yet the shares now screen as overvalued on market multiples even while the broader valuation checks lean supportive. That mix of a big past gain with a richer pricing signal is what investors are trying to make sense of today. Over the last three years GEO Group has returned 317.1%, which puts a lot of past gains on the table and raises the bar for any new buyers at current levels. New federal immigration...

Texas Instruments stock has returned 79.2% over the past three years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and traditional market multiples currently point to the shares trading at a premium. With a value score that is on the low side, investors are weighing strong recent gains against signals that the stock may be priced above its underlying cash flow outlook. Texas Instruments has delivered a 79.2% return over three years, which puts extra focus on whether the...

Penumbra, Inc. recently initiated a voluntary Class II recall of its Penumbra System RED 68 Reperfusion Catheter across multiple US states and international markets due to manufacturing issues that may cause catheter fractures, following firm notifications sent out in early June 2026. This recall comes shortly after Penumbra reported higher quarterly sales of US$390.05 million but lower net income of US$34.81 million and reduced earnings per share versus a year earlier, highlighting growing...

Sionna Therapeutics recently reported that its Phase 2a PreciSION CF trial of NBD1 stabilizer SION-719 added to Trikafta did not improve sweat chloride levels, leading the company to discontinue SION-719 as an add-on therapy and to reassess its clinical plans. At the same time, early data from SION-451 combination studies and a cash balance of about US$268.3 million give Sionna room to reconsider how it pursues cystic fibrosis therapies while preserving capital. We’ll now examine how...

Cipher Digital Inc. has released its second-quarter 2026 results, reporting sales of US$24.84 million versus US$43.57 million a year earlier, alongside a net loss of US$267.53 million that widened markedly from US$45.78 million. Over the first half of 2026, the company’s sales fell to US$59.68 million while its net loss expanded to US$381.85 million, sharply increasing loss per share even as Cipher continues to promote its evolution into a broader digital infrastructure provider. We will now...

As AI moves from buzzword to core toolkit for tracking inflation, jobs and growth in real time, investors are no longer limited to slow, revision prone government reports. That shift is creating a data gap between companies that power these new insights and everyone else, and missing it could mean missing the next big story. This article walks through three AI and data analytics stocks exposed to that news and explains why they stand out right now. The three stocks highlighted below are just...